BrainSee Enterprise Software Is Reliable, Accurate for Alzheimer’s Disease Detection, featuring Darmiyan
Today the American Society of Neuroradiology published Introducing BrainSee, a summary of study results presenting the 91 percent accuracy rate of the new AI-powered and patented technology by Darmiyan Inc. that detects Alzheimer’s disease at early stages of disease development. Read More →